Lisanti Capital Growth, LLC Adma Biologics, Inc. Transaction History
Lisanti Capital Growth, LLC
- $371 Million
- Q4 2024
A detailed history of Lisanti Capital Growth, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Lisanti Capital Growth, LLC holds 175,470 shares of ADMA stock, worth $2.72 Million. This represents 0.81% of its overall portfolio holdings.
Number of Shares
175,470
Previous 235,035
25.34%
Holding current value
$2.72 Million
Previous $4.7 Million
35.95%
% of portfolio
0.81%
Previous 1.37%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$289 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$282 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$231 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$175 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$85.9 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.05B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...